Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: GPC3/Mesothelin-CAR-γδT Cells Against Cancers [Phase 1]
Phase 1 clinical trial evaluating GPC3/Mesothelin-CAR-γδT cells for pancreatic, lung, liver cancers and mesothelioma; currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers [Phase 1]
Phase 1 clinical trial assessing mesothelin/GPC3/GUCY2C-targeted CAR-T cells for pancreatic cancer and other solid tumors; recruitment is on…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients [Phase 2]
Phase 2 clinical trial status update for a PD-1 inhibitor combined with chemotherapy and PULSAR in locally advanced and recurrent pancreatic…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for a triplex checkpoint inhibitor therapy evaluating safety and efficacy in advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study examining trans-arterial/intra-tumor infusion of checkpoint inhibitors plus chemotherapy f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Role of Pre-operative CPET in Pancreatoduodenectomy
A completed clinical trial evaluating the role of pre-operative CPET in patients undergoing pancreatoduodenectomy for pancreatic and periamp…
-
CLINICAL_TRIALS research · 2024-06-14Clinical Trial Update: Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Azeliragon for metastatic pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness [Phase 4]
A Phase 4 clinical trial is evaluating a pharmacokinetic boosting strategy for olaparib to improve exposure and tolerability, with a focus o…
-
CLINICAL_TRIALS research · 2024-06-07Clinical Trial Update: Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline
This prospective registry of patients with resectable and borderline resectable pancreatic cancer has completed data collection.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer [Phase 2]
Phase 2 clinical trial investigating whether high-dose Vitamin C can improve quality of life in patients with metastatic pancreatic cancer; …
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: The Effect of Probiotics ATG-F4 in Cancer Patients [Phase 2]
A Phase 2 trial is evaluating the probiotic ATG-F4 in patients with pancreatic cancer and colorectal cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: U87 CART in Treatment of Advanced Solid Tumor [Phase 1]
Phase 1 clinical trial update for U87 CART therapy in adults with advanced solid tumors, including pancreatic cancer; trial status is UNKNOW…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer [Phase 1]
This Phase 1 study evaluates the efficacy and safety of CT041 in pancreatic cancer patients after adjuvant chemotherapy.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating nimotuzumab plus NALIRIFOX for locally advanced pancreatic cancer is listed as ACTIVE_NOT_RECRUITING; sponsor is Pe…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Pancreatic Cancer Early Detection Program
A clinical trial update for White Plains Hospital describes an active, not currently recruiting program focused on early detection of pancre…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) [Phase 2]
The CBART trial (Central-boost Ablative Radiation Therapy) for pancreatic cancer is a Phase 2 study currently recruiting to evaluate this ra…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating the combination of SBRT, nimotuzumab, and mono-chemotherapy for locally advanced pancreatic cancer; t…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Prospective clinical trial evaluating whether peripheral blood cell-free DNA sequencing can screen for and differentiate among several commo…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer [Phase 2]
Clinical trial update on a Phase 2 study evaluating a modified FOLFIRINOX regimen alternated with biweekly gemcitabine plus nab-paclitaxel i…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
Adenocyte's LINFU U.S. Registry study for patients with pancreatic cancer presenting with signs or symptoms is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study of nimotuzumab combined with GX as postoperative adjuvant therapy in pancreatic cancer, no…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating HR070803 in combination with oxaliplatin and 5-FU/leucovorin versus AG for first-line treatment of advanced pancrea…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study [Phase 2]
A phase II, single-arm trial is evaluating nimotuzumab in combination with the AG regimen (gemcitabine plus nab-paclitaxel) for pancreatic c…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With Chemotherapy [NA]
A completed pilot clinical trial evaluates whether a high-protein supplement plus exercise therapy preserves skeletal muscle mass and improv…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Two Chemotherapy Regimens Plus or Minus Bevacizumab [Phase 2]
This Phase 2 trial in pancreatic cancer compares two chemotherapy regimens with or without bevacizumab and is currently active but not recru…